Drug repurposing in KRAS G12C-mutant NSCLC: a focus on resistance mechanisms and clinical strategies. - Jain A; Rosell R; Dharmashekara C; Shreevatsa B; González-Cao M; Shivakumar A; Kollur SP; Prasad A; Shivamallu C; Prasad MNN (Naunyn-Schmiedeberg's archives of pharmacology, 2026)